HOME Top Market Reports Point-Of-Care Diagnostics / Testing Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018

Point-Of-Care Diagnostics / Testing Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018

By: marketsandmarkets.com
Publishing Date: March 2014
Report Code: MD 2328

 

  Speak to Analyst Enquiry Before Buying
 
purchase report
download pdf  request for customisation


The global Point-Of-Care Diagnostics market is broadly categorized into infectious diseases testing kits, glucose monitoring kits, coagulation monitoring kits, urinalysis testing kits, hematology testing kits, cholesterol test strips, drugs of abuse testing kits, cardiac markers, blood gas/electrolytes testing kits, tumor/cancer markers, pregnancy and fertility testing kits, fecal occult testing kits, food pathogens testing kits, and others. The glucose monitoring kits segment accounted for the largest share of the market in 2013, while cardiac markers segment is expected to grow at the highest CAGR in the forecast period.

Moreover, the global market has also been classified on the basis of end users and prescription mode. Based on the end users, the global point of care diagnostics / tesing market is segmented into patient professional monitoring kits and patient self-monitoring kits. Furthermore, based on the prescription mode, the global market has been segmented into OTC and prescription-based testing kits market. Based on geography, the market is divided into North America, Asia-Pacific, Europe, and the Rest of the World (RoW).

A number of factors such as the rising prevalence of lifestyle and infectious diseases, increasing usage of home-based POC devices, technological advancements, and decreasing number of technicians in the central labs are driving the growth of the market. In addition, factors such as growing government support, expansion of therapeutic horizon, and increasing private investments and venture funding to support new product developments are further stimulating the growth of the point-of-care diagnostics market. However, factors such as lack of alignment with definitive central lab methods, reluctance to change existing treatment practices, and recalls of leading glucose monitoring devices are restraining the growth of the market.

In 2013, North America held the largest share in the global market, followed by Asia-Pacific, Europe, and the RoW (Rest of the World). The Asia-Pacific region (comprising Japan, China, India, and the Rest of Asia-Pacific) is estimated to grow at the highest CAGR in the forecast period. Factors such as the huge patient population base, large number of R&D activities, growing focus of both international and domestic players on the Asia-Pacific Point-Of-Care diagnostics market, and increasing funding/investment towards the development of Point-Of-Care Diagnostics / Testing products are driving the growth of the point-of-care diagnostics / testing market in the Asia-Pacific region.

The market is a diversified and competitive market, with a large number of players. The market (excluding blood glucose monitoring kits market) is dominated by various players, depending on their core competencies. The key players in this market are Roche Diagnostics Ltd. (Switzerland), Alere Inc. (U.S.), Siemens AG (Germany), and Beckman Coulter, Inc. (U.S.). Whereas, the key players in the global blood glucose monitoring kits market are Roche Diagnostics Limited (Switzerland), Johnson & Johnson (U.S.), Bayer AG (Germany), and Abbott Laboratories (U.S.).

Scope of the Report

This research report categorizes the Point-Of-Care Diagnostics market into the following segments and subsegments:

Global Point-Of-Care Diagnostics Market, By Product

  • Infectious Diseases Testing Kits
    • Influenza Testing Kits
    • HIV Testing Kits
    • Hepatitis Testing Kits
    • Sexually-Transmitted Diseases Testing Kits
    • Tuberculosis Testing Kits
    • Tropical Diseases Testing Kits
  • Glucose Monitoring Kits
    • Glucose Monitoring Strips
    • Glucose Monitoring Devices
    • Lancets
  • Coagulation Monitoring Kits
    • Prothrombin Time (PT/INR) Testing Kits
    • Activated Clotting Time (ACT/APTT) Testing Kits
  • Urinalysis Testing Kits
  • Hematology Testing Kits
    • Hemoglobin Assay Kits
    • Hemostasis Assay Kits
  • Cholesterol Test Strips
  • Drugs of Abuse Testing Kits
  • Cardiac Markers
  • Blood Gas/Electrolytes Testing Kits
  • Tumor/Cancer Markers
  • Pregnancy and Fertility Testing Kits
    • Pregnancy Testing Kits
    • Fertility Testing Kits
  • Fecal Occult Testing Kits
  • Food Pathogens Testing Kits
  • Others

Global Point-Of-Care Diagnostics Market, By Prescription Mode

  • Over-the-counter (OTC) Testing Kits
  • Prescription-based Testing Kits

Global Point-Of-Care Diagnostics Market, By End User

  • Professional Monitoring Kits
    • Inpatient Monitoring Kits
    • Outpatient Monitoring Kits
    • Special Areas Monitoring Kits
    • Others
  • Patients Self-Monitoring Kits

Point-Of-Care Diagnostics Market, By Geography

  • North America
  • Asia-Pacific
  • Europe
  • RoW (Rest of the World)

Customization Options:

With the given market data, MarketsandMarkets offer customizations as per the Company’s specific needs. The following customization options are available for the report –

  • Product Analysis
    • Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level   OR
    • Product Matrix which gives a detailed comparison of product portfolio of each company   OR
    • Comprehensive coverage of Product approvals, Pipeline products, and Product recalls
  • Epidemiology Data
    • Country specific prevalence for various diseases where point of care devices are used for their diagnosis
  • Geographic Analysis
    • Further breakdown of the Rest of Asia-Pacific POC diagnostics market into South Korea, Australia, and New Zealand, and others   OR
    • Further breakdown of the Latin American POC diagnostics market into Brazil, Argentina, and Rest of Latin America
  • Company Information
    • Detailed analysis and profiling of additional market players (Upto 5)

Table of Contents 
 
1Introduction (Page No. - 25)
 1.1 Objectives Of The Study
 1.2 Report Description
  1.3 Markets Covered
  1.4 Stakeholders
  1.5 Market Scope
  1.6 Research Methodology
      1.6.1 Market Size Estimation
      1.6.2 Market Crackdown & Data Triangulation
      1.6.3 Market Share Estimation
      1.6.4 Key Data Points From Secondary Sources
      1.6.5 Key Data Points From Primary Sources
      1.6.6 Assumptions

2 Executive Summary (Page No. - 37)

3 Premium Insights (Page No. - 42)
  3.1 Product Growth Matrix
  3.2 Life Cycle Analysis, By Geography
  3.3 Market Chasm Analysis

4 Market Overview (Page No. - 47)
  4.1 Introduction
  4.2 Evolution
  4.3 Market Segmentation
      4.3.1 Point of Care Diagnostics Market By Product
      4.3.2 Point of Care Diagnostics Market By Prescription Mode
      4.3.3 Point of Care Diagnostics Market By End User
  4.4 Market Dynamics
      4.4.1 Drivers
            4.4.1.1 Huge prevalence of infectious diseases in developing countries
            4.4.1.2 Increasing incidences of lifestyle diseases (cardiac diseases and diabetes)
            4.4.1.3 Rising usage of home-based POC devices is improving patient compliance
            4.4.1.4 Private investments and venture funding to support development of new products
            4.4.1.5 Growing government support to magnify the adoption of POC devices
            4.4.1.6 Expansion of therapeutic horizon
            4.4.1.7 Fostering approval of novel immunoassay techniques
            4.4.1.8 Technological advancements
            4.4.1.9 Large number of awareness campaigns/ conferences in developing countries
            4.4.1.10 Decreasing number of technicians available in central labs
      4.4.2 Restraints
            4.4.2.1 Lack of alignment with definitive central lab methods
            4.4.2.2 Disadvantages of point-of-care diagnostics / testing over central lab methods
            4.4.2.3 Recall of leading glucose monitoring devices
            4.4.2.4 Reluctance to change the existing treatment practices
      4.4.3 Oppurtunities
            4.4.3.1 Emerging markets(India, China, and Brazil)
            4.4.3.2 Healthcare decentralization
            4.4.3.3 Miniaturization of point-of-care diagnostics / testing devices
      4.4.4 Challenges
            4.4.4.1 Growing price-cutting measures
            4.4.4.2 Stringent and time-consuming regulatory policies
      4.4.5 Burning Issues
            4.4.5.1 Unfavorable reimbursement scenario in many countries
            4.4.5.2 High cost of POC devices
      4.4.6 Winning Imperatives
            4.4.6.1 Strategy of geographic expansion in emerging markets
            4.4.6.2 Strategy of development of low-cost POC devices
            4.4.6.3 Strategy of development of multi-assay POC devices

5 Industry Trends (Page No. - 68)
  5.1 Introduction
  5.2 Value Chain Analysis
  5.3 Supply Chain Analysis
      5.3.1 Key Influencers:
  5.4 Industry Trends
      5.4.1 Standardization of point-of-care diagnostics / testing Devices
      5.4.2 Acquisition Of Small Players
      5.4.3 Growing Focus On Microfluidics-Based Poc Devices
            5.4.3.1 Microfluidic technology based lab-on-a-chip devices will bring laboratory testing to patient’s finger tips
  5.5 Pricing And Cost Analysis
  5.6 Porter’s Five Forces Analysis
      5.6.1 Threat From New Entrants
      5.6.2 Threat From Substitutes
      5.6.3 Bargaining Power Of Suppliers
      5.6.4 Bargaining Power Of Buyers
      5.6.5 Intensity Of Competitive Rivalry
  5.7 PEST Analysis
      5.7.1 Political Factors
      5.7.2 Economic Factors
      5.7.3 Social Factors
      5.7.4 Technological Factors
  5.8 Strategic Benchmarking
      5.8.1 Technology Integration & Product Enhancement
      5.8.2 Entry Into Tumor/Cancer Testing Market

6 Point-Of-Care Diagnostics Market, By Product (Page No. - 89)
  6.1 Introduction
  6.2 Glucose Monitoring Kits Market
      6.2.1 Glucose Monitoring Strips Market
      6.2.2 Glucose Monitoring Devices Market
      6.2.3 Lancets Market
  6.3 Cardiac Markers Market
  6.4 Infectious Dieases Testing Kits Market
      6.4.1 Influenza Testing Kits Market
      6.4.2 Hiv Testing Kits Market
      6.4.3 Hepatitis b Testing Kits Market
      6.4.4 Sexually-Transmitted Diseases (STDS) testing Kits Market
      6.4.5 Tuberculosis (TB) Testing Kits Market
      6.4.6 Tropical Diseases Testing Kits Market
  6.5 Coagulation Monitoring Kits Market
      6.5.1 Prothrombin Time (PT/INR) Testing Kits Market
      6.5.2 Activated Clotting Time (ACT/APTT) Testing Kits Market
  6.6 Pregnancy And Fertility Testing Kits Market
      6.6.1 Pregnancy Testing Kits Market
      6.6.2 Fertility Testing Kits Market
  6.7 Blood Gas/Electrolytes Testing Kits Market
  6.8 Tumor/Cancer Markers Market
      6.8.1 Urinalysis Testing Kits Market
  6.9 Cholesterol Test Strips Market
  6.10 Hematology Testing Kits Market
       6.10.1 Hemoglobin Assay Kits Market
       6.10.2 Hemostasis Assay Kits Market
  6.11 Food Pathogens Testing Kits Market
  6.12 Drugs Of Abuse Testing Kits Market
  6.13 Fecal Occult Testing Kits Market
  6.14 Other Testing Kits Market

7 Point-Of-Care Diagnostics Market, By Prescription Mode (Page No. - 143)
  7.1 Introduction
  7.2 Prescription-Based Testing Kits Market
  7.3 Otc Testing Kits Market

8 Point-Of-Care Diagnostics Market, By End User (Page No. - 151)
  8.1 Introduction
  8.2 Patient Professional Monitoring Kits Market
      8.2.1 Inpatient Monitoring Kits Market
      8.2.2 Outpatient Monitoring Kits Market
      8.2.3 Special Areas Monitoring Kits Market
      8.2.4 Other Areas Professional Monitoring Kits Market
  8.3 Patient Self-Monitoring Kits Market

9 Point-Of-Care Diagnostics Market, By Geography (Page No. - 163)
  9.1 Introduction
  9.2 North America
      9.2.1 U.S.
      9.2.2 Canada
      9.2.3 Mexico
  9.3 Europe
      9.3.1 Germany
      9.3.2 France
      9.3.3 U.K.
      9.3.4 Italy
      9.3.5 Spain
      9.3.6 Rest Of Europe (ROE)
  9.4 Asia-Pacific
      9.4.1 Japan
      9.4.2 China
      9.4.3 India
      9.4.4 Rest Of Asia-Pacific
  9.5 Rest Of The World (Row)
      9.5.1 Latin America
      9.5.2 Africa
      9.5.3 Middle East

10 Competitive Landscape (Page No. - 307)
   10.1 Overview
   10.2 Market Share Analysis, Point-Of-Care Diagnostics / Testing Market (Excluding Blood Glucose Monitoring Kits)
   10.3 Market Share Analysis, Blood Glucose Monitoring Kits Market
   10.4 Competitive Situation And Trends
   10.5 New Product Launches
   10.6 Agreements, Partnerships, Collaborations, & Joint Ventures
   10.7 Mergers And Acquisitions
   10.8 Expansions
   10.9 Other Developments

11 Company Profiles (Page No. - 342)
   11.1 Abaxis, Inc.
        11.1.1 Overview
        11.1.2 Financials
        11.1.3 Products & Services
        11.1.4 Strategy
        11.1.5 Developments
   11.2 Abbott Laboratories, Inc.
        11.2.1 Overview
        11.2.2 Financials
        11.2.3 Products & Services
        11.2.4 Strategy
        11.2.5 Developments
        11.2.6 Swot Analysis
        11.2.7 MNM View
   11.3 Alere, Inc.
        11.3.1 Overview
        11.3.2 Financials
        11.3.3 Products & Services
        11.3.4 Strategy
        11.3.5 Developments
        11.3.6 Swot Analysis
        11.3.7 MnM view
   11.4 Bayer Healthcare ag (A Subsidiary Of Bayer ag)
        11.4.1 Overview
        11.4.2 Financials
        11.4.3 Products & Services
        11.4.4 Key Strategy
        11.4.5 Developments
   11.5 Beckman Coulter, Inc. (A Subsidiary Of Danaher Corporation) 
        11.5.1 Overview
        11.5.2 Financials
        11.5.3 Products & Services
        11.5.4 Strategy
        11.5.5 Developments
  11.6 Becton, Dickinson And Company
       11.6.1 Overview
       11.6.2 Financials
       11.6.3 Products & Services
       11.6.4 Strategy
       11.6.5 Developments
  11.7 Johnson & Johnson
       11.7.1 Overview
       11.7.2 Financials
       11.7.3 Products & Services
       11.7.4 Strategy
       11.7.5 Developments
   11.8 Nipro Diagnostics, Inc. (A Subsidiary Of Nipro Corporation) 
        11.8.1 Overview
        11.8.2 Financials
        11.8.3 Products & Services
        11.8.4 Strategy
        11.8.5 Developments
   11.9 Roche Diagnostics Limited (A Subsidairy Of F. Hoffmann-La Roche Ltd) 
        11.9.1 Overview
        11.9.2 Financials
        11.9.3 Products & Services
        11.9.4 Strategy
        11.9.5 Developments
        11.9.6 Swot Analysis
        11.9.7 MnM View
   11.1 Siemens Healthcare (A Division Of Siemens ag) 
        11.10.1 Overview
        11.10.2 Financials
        11.10.3 Products & Services
        11.10.4 Strategy
        11.10.5 Developments 
   
List Of Tables  (198 Tables)
    
Table 1 Global Point of Care Diagnostics Market, By Product, 2011–2018 ($Million) 
Table 2 Global Glucose Monitoring Kits Market, By Type, 2011–2018 ($Million) 
Table 3 Glucose Monitoring Kits Market, By Geography, 2011–2018 ($Million) 
Table 4 Glucose Monitoring Strips Market, By Geography, 2011–2018 ($Million) 
Table 5 Glucose Monitoring Devices Market, By Geography, 2011–2018 ($Million) 
Table 6 Lancets Market, By Geography, 2011–2018 ($Million)
Table 7 Cardiac Markers Market, By Geography, 2011–2018 ($Million)
Table 8 Global Infectious Diseases Testing Kits Market, By Product, 2011–2018 ($Million)
Table 9 Infectious Diseases Testing Kits Market, By Geography, 2011–2018 ($Million) 
Table 10 Influenza Testing Kits Market, By Geography, 2011–2018 ($Million) 
Table 11 Hiv Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 12 Hepatitis B Testing Kits Market, By Geography, 2011–2018 ($Million) 
Table 13 Stds Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 14 Tb Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 15 Tropical Diseases Testing Kits Market, By Geography, 2011–2018 ($Million) 
Table 16 Global Coagulation Monitoring Kits Market, By Type, 2011–2018 ($Million) 
Table 17 Coagulation Monitoring Kits Market, By Geography, 2011–2018 ($Million) 
Table 18 Prothrombin Time (Pt/Inr) Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 19 Activated Clotting Time (Act/Aptt) Testing Kits Market, By Geography, 2011–2018 ($Million) 
Table 20 Global Pregnancy And Fertility Testing Kits Market, By Type, 2011–018 ($Million)
Table 21 Pregnancy And Fertility Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 22 Pregnancy Testing Kits Market, By Geography, 2011–2018 ($Million) 
Table 23 Fertility Testing Kits Market, By Geography, 2011–2018 ($Million) 
Table 24 Blood Gas/Electrolytes Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 25 Tumor/Cancer Markers Market, By Geography, 2011–2018 ($Million) 
Table 26 Urinalysis Testing Kits Market, By Geography, 2011–2018 ($Million) 
Table 27 Cholestrol Test Strips Market, By Geography, 2011–2018 ($Million) 
Table 28 Global Hematology Testing Kits Market, By Type, 2011–2018 ($Million) 
Table 29 Hematology Testing Kits Market, By Geography, 2011–2018 ($Million) 
Table 30 Hemoglobin Assay Kits Market, By Geography, 2011–2018 ($Million) 
Table 31 Hemostasis Assay Kits Market, By Geography, 2011–2018 ($Million) 
Table 32 Food Pathogens Testing Kits Market, By Geography, 2011–2018 ($Million) 
Table 33 Drugs Of Abuse Testing Kits Market, By Geography, 2011–2018 ($Million) 
Table 34 Fecal Occult Testing Kits Market, By Geography, 2011–2018 ($Million) 
Table 35 Other Testing Kits Market, By Geography, 2011–2018 ($Million) 
Table 36 Global POC Diagnostics Market, By Prescription Mode, 2011–2018 ($Million) 
Table 37 Prescription-Based Testing Kits Market, By Geography, 2011–2018 ($Million) 146
Table 38 Otc Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 39 Global Point of Care Diagnostics Market, By End User, 2011–2018 ($Million) 
Table 40 Patient Professional Monitoring Kits Market, By Type, 2011–2018 ($Million) 
Table 41 Inpatient Monitoring Kits Market, By Geography, 2011–2018 ($Million) 
Table 42 Outpatient Monitoring Kits Market, By Geography, 2011–2018 ($Million) 
Table 43 Special Areas Monitoring Kits Market, By Geography, 2011–2018 ($Million) 
Table 44 Other Areas Professional Monitoring Kits Market, By Geography, 2011–2018 ($Million) 160
Table 45 Patient Self-Monitoring Kits Market, By Geography, 2011?–2018 ($Million) 
Table 46 POC Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 47 North America: POC Diagnostics Market, By Country, 2011–2018 ($Million) 
Table 48 North America: Point-Of-Care Diagnostics/ Testing Market, By Product, 2011–2018 ($Million) 
Table 49 North America: Glucose Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 50 North America: Cardiac Markers Market, By Country, 2011–2018 ($Million) 
Table 51 North America: Infectious Diseases Testing Kits Market, By Country, 2011–2018 ($Million) 
Table 52 North America: Coagulation Monitoring Kits Market, By Country, 2011–2018 ($Million) 
Table 53 North America: Pregnancy And Fertility Testing Kits Market, By Country, 2011–2018 ($Million)
Table 54 North America: Blood Gas And Electrolytes Testing Kits Market, By Country, 2011–2018 ($Million)
Table 55 North America: Tumor/Cancer Markers Market, By Country, 2011–2018 ($Million)
Table 56 North America: Urinalysis Testing Kits Market, By Country, 2011–2018 ($Million)
Table 57 North America: Cholestrol Test Strips Market, By Country, 2011–2018 ($Million)
Table 58 North America: Hematology Testing Kits Market, By Country, 2011–2018 ($Million)
Table 59 North America: Food Pathogens Testing Kits Market, By Country, 2011–2018 ($Million) 
Table 60 North America: Drugs Of Abuse Testing Kits Market, By Country, 2011–2018 ($Million) 
Table 61 North America: Fecal Occult Testing Kits Market, By Country, 2011–2018 ($Million) 
Table 62 North America: Other Testing Kits Market, By Country, 2011–2018 ($Million) 
Table 63 North America: Market, By Prescription Mode, 2011–2018 ($Million)
Table 64 North America: Otc Testing Kits Market, By Country, 2011–2018 ($Million) 
Table 65 North America: Prescription-Based Testing Kits Market, By Country, 2011–2018 ($Million) 
Table 66 North America: Point-Of-Care Diagnostics / Testing Market, By End-User, 2011–2018 ($Million) 
Table 67 North America: Patient Self–Monitoring Kits Market, By Country, 2011–2018 ($Million) 
Table 68 North America: Professional Monitoring Kits Market, By Country, 2011–2018 ($Million) 
Table 69 U.S: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 70 U.S.: Market, By Prescription Mode, 2011–2018 ($Million) 
Table 71 U.S.: Market, By End User, 2011–2018 ($Million)
Table 72 Canada: Market, By Product, 2011–2018 ($Million)
Table 73 Canada: Market, By Prescription Mode, 2011–2018 ($Million) 
Table 74 Canada: Market, By End User, 2011–2018 ($Million)
Table 75 Mexico: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 76 Mexico: Market, By Prescription Mode, 2011–2018 ($Million) 
Table 77 Mexico: Market, By End User, 2011–2018 ($Million)
Table 78 Europe: Market, By Country, 2011–2018 ($Million)
Table 79 Europe: Market, By Product, 2011–2018 ($Million)
Table 80 Europe: Glucose Monitoring Kits Market, By Country, 2011–2018 ($Million) 
Table 81 Europe: Cardiac Markers Market, By Country, 2011–2018 ($Million)
Table 82 Europe: Infectious Diseases Testing Kits Market, By Country, 2011–2018 ($Million)
Table 83 Europe: Coagulation Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 84 Europe: Pregnancy And Fertility Kits Market, By Country, 2011–2018 ($Million)
Table 85 Europe: Blood Gas And Electrolytes Testing Kits Market, By Country, 2011–2018 ($Million) 
Table 86 Europe: Tumor/Cancer Markers Market, By Country, 2011–2018 ($Million)
Table 87 Europe: Urinalysis Testing Kits Market, By Country, 2011–2018 ($Million) 
Table 88 Europe: Cholestrol Test Strips Market, By Country, 2011–2018 ($Million) 
Table 89 Europe: Hematology Testing Kits Market, By Country, 2011–2018 ($Million) 
Table 90 Europe: Food Pathogens Testing Kits Market, By Country, 2011–2018 ($Million)
Table 91 Europe: Drugs Of Abuse Testing Kits Market, By Country, 2011–2018 ($Million)
Table 92 Europe: Fecal Occult Testing Kits Market, By Country, 2011–2018 ($Million) 
Table 93 Europe: Other Testing Kits Market, By Country, 2011–2018 ($Million)
Table 94 Europe: POC Diagnostics Market, By Prescription Mode, 2011–2018 ($Million) 
Table 95 Europe: Otc Testing Kits Market, By Country, 2011–2018 ($Million)
Table 96 Europe: Prescription-Based Testing Kits Market, By Country, 2011–2018 ($Million)
Table 97 Europe: POC Diagnostics Market, By End User, 2011–2018 ($Million)
Table 98 Europe: Patient Self-Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 99 Europe: Professional Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 100 Germany: Market, By Product, 2011–2018 ($Million)
Table 101 Germany: Market, By Prescription Mode, 2011–2018 ($Million)
Table 102 Germany: Market, By End User, 2011–2018 ($Million)
Table 103 France: Market, By Product, 2011–2018 ($Million)
Table 104 France: Market, By Prescription Mode, 2011–2018 ($Million) 
Table 105 France: Point-Of-Care Diagnostics Market, By End User, 2011–2018 ($Million)
Table 106 U.K.: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 107 U.K.: POC Market, By Prescription Mode, 2011–2018 ($Million) 
Table 108 U.K.: Market, By End User, 2011–2018 ($Million)
Table 109 Italy: Market, By Product, 2011–2018 ($Million)
Table 110 Italy: Point-Of-Care Diagnostics / Testing Market, By Prescription Mode, 2011–2018 ($Million) 
Table 111 Italy: Market, By End User, 2011–2018 ($Million)
Table 112 Spain: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 113 Spain: Point-Of-Care Diagnostics / Testing Market, By Prescription Mode, 2011–2018 ($Million) 
Table 114 Spain: Market, By End User, 2011–2018 ($Million)
Table 115 ROE: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 116 ROE: Point-Of-Care Diagnostics / Testing Market, By Prescription Mode, 2011–2018 ($Million) 
Table 117 ROE: Market, By End User, 2011–2018 ($Million)
Table 118 Asia-Pacific: Point-Of-Care Diagnostics Market, By Country, 2011–2018 ($Million)
Table 119 Asia-Pacific: Market, By Product, 2011–2018 ($Million)
Table 120 Asia-Pacific: Glucose Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 121 Asia-Pacific: Cardiac Markers Market, By Country, 2011–2018 ($Million)
Table 122 Asia-Pacific: Infectious Diseases Testing Kits Market, By Country, 2011–2018 ($Million) 
Table 123 Asia-Pacific: Coagulation Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 124 Asia-Pacific: Pregnancy And Fertility Kits Market, By Country, 2011–2018 ($Million)
Table 125 Asia-Pacific: Blood Gas And Electrolytes Testing Kits Market, By Country, 2011–2018 ($Million)
Table 126 Asia-Pacific: Tumor/Cancer Markers Market, By Country, 2011–2018 ($Million)
Table 127 Asia-Pacific: Urinalysis Testing Kits Market, By Country, 2011–2018 ($Million)
Table 128 Asia-Pacific: Cholestrol Test Strips Market, By Country, 2011–2018 ($Million)
Table 129 Asia-Pacific: Hematology Testing Kits Market, By Country, 2011–2018 ($Million)
Table 130 Asia-Pacific: Food Pathogens Testing Kits Market, By Country, 2011–2018 ($Million)
Table 131 Asia-Pacific: Drugs Of Abuse Testing Kits Market, By Country, 2011–2018 ($Million)
Table 132 Asia-Pacific: Fecal Occult Testing Kits Market, By Country, 2011–2018 ($Million)
Table 133 Asia-Pacific: Other Testing Kits Market, By Country, 2011–2018 ($Million) 
Table 134 Asia-Pacific: Point-Of-Care Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 135 Asia-Pacific : Otc Testing Kits Market, By Country, 2011–2018 ($Million)
Table 136 Asia-Pacific: Prescription-Based Testing Kits Market, By Country, 2011–2018 ($Million)
Table 137 Asia-Pacific: Poc Diagnostics Market, By End User, 2011–2018 ($Million)
Table 138 Asia-Pacific: Patient Self-Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 139 Asia-Pacific: Professional Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 140 Japan: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 141 Japan: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million) 
Table 142 Japan: Market, By End User, 2011–2018 ($Million)
Table 143 China: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 144 China: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million) 
Table 145 China: Market, By End User, 2011–2018 ($Million)
Table 146 India: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 147 India: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million) 
Table 148 India: Market, By End User, 2011–2018 ($Million)
Table 149 ROAa: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 150 ROA: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million) 
Table 151 ROA: Market, By End User, 2011 – 2018 ($Million)
Table 152 ROW: Point-Of-Care Diagnostics Market, By Region, 2011–2018 ($Million)
Table 153 ROW: Market, By Product, 2011–2018 ($Million)
Table 154 ROW: Glucose Monitoring Kits Market, By Region, 2011–2018 ($Million)
Table 155 ROW: Cardiac Markers Market, By Region, 2011–2018 ($Million)
Table 156 ROW: Infectious Diseases Testing Kits Market, By Region, 2011–2018 ($Million)
Table 157 ROW: Coagulation Monitoring Kits Market, By Region, 2011–2018 ($Million) 
Table 158 ROW: Pregnancy And Fertility Kits Market, By Region, 2011–2018 ($Million) 
Table 159 ROW: Blood Gas And Electrolytes Testing Kits Market, By Region, 2011–2018 ($Million)
Table 160 ROW: Tumor/Cancer Markers Market, By Region, 2011–2018 ($Million)
Table 161 ROW: Urinalysis Testing Kits Market, By Region, 2011–2018 ($Million)
Table 162 ROW: Cholestrol Test Strips Market, By Region, 2011–2018 ($Million)
Table 163 ROW: Hematology Testing Kits Market, By Region, 2011–2018 ($Million)
Table 164 ROW: Food Pathogens Testing Kits Market, By Region, 2011–2018 ($Million) 
Table 165 ROW: Drugs Of Abuse Testing Kits Market, By Region, 2011–2018 ($Million) 
Table 166 ROW: Fecal Occult Testing Kits Market, By Region, 2011–2018 ($Million)
Table 167 ROW: Other Testing Kits Market, By Region, 2011–2018 ($Million)
Table 168 ROW: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million) 
Table 169 ROW: Otc Testing Kits Market, By Region, 2011–2018 ($Million)
Table 170 ROW: Prescription-Based Testing Kits Market, By Region, 2011–2018 ($Million)
Table 171 ROW: Poc Diagnostics Market, By Enduser, 2011–2018 ($Million)
Table 172 ROW: Patient Self-Monitoring Kits Market, By Region, 2011–2018 ($Million) 
Table 173 ROW: Professional Monitoring Kits Market, By Region, 2011–2018 ($Million) 
Table 174 Latin America: Point-Of-Care Diagnostics Market, By Product, 2011 – 2018 ($Million) 
Table 175 Latin America: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 176 Latin America: tics Market, By End User, 2011–2018 ($Million) 
Table 177 Africa: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 178 Africa: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million) 
Table 179 Africa: Market, By End User, 2011–2018 ($Million)
Table 180 Middle East: Point-Of-Care  Diagnostics Market, By Product, 2011–2018 ($Million)
Table 181 Middle East: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 182 Middle East: Market, By End User, 2011–2018 ($Million)
Table 183 New Product Launches, 2011–2014
Table 184 Agreements, Partnerships, Collaborations, And Joint Ventures, 2011–2014
Table 185 Mergers And Acquisitions, 2011–2014
Table 186 Expansion, 2011–2014
Table 187 Other Developments, 2011 – 2014
Table 188 Abaxis, Inc.: Total Revenue And R&D Expenditure, 2011–2013 ($Million)
Table 189 Abbott Laboratories, Inc.: Total Revenue And R&D Expenditure, 2010–2012 ($Million)
Table 190 Alere, Inc.: Total Revenue And R&D Expenditure, 2010–2012 ($Million)
Table 191 Bayer Ag: Total Revenue And R&D Expenditure, 2010–2012 ($Million)
Table 192 Danaher Corporation: Total Revenue, 2010–2012 ($Million)
Table 193 Danaher Corporation: Total Revenue, By Segment, 2010–2012 ($Million)
Table 194 Becton, Dickinson And Company: Total Revenue And R&D Expenditure, 2011–2013 ($Million)
Table 195 Johnson & Johnson: Total Revenue And R&D Expenditure, 2010–2012 ($Million)
Table 196 Nipro Corporation: Total Revenue And R&D Expenditure, 2011–2013 ($Million)
Table 197 Roche Diagnostics Limited: Total Revenue And R&D Expenditure, 2011–2013 ($Million)
Table 198 Siemens Healthcare: Total Revenue And R&D Expenditure, 2011–2013 ($Million) 
  
List of Figures   (48 Figures)
  
Figure 1 Global Point-Of-Care Diagnostics Market: Research Methodology
Figure 2 Market Size Estimation Methodology
Figure 1 Global Point-Of-Care Diagnostics Market, By Product, 2013
Figure 2 Global Point-Of-Care Diagnostics Market, By Geography, 2013
Figure 3 Product Growth Matrix
Figure 4 Point-Of-Care Diagnostics Market Life Cycle Analysis: By Geography
Figure 5 Point-Of-Care Diagnostics Market: Chasm Analysis
Figure 6 Evolution Of Poctesting
Figure 7 Point-Of-Care Diagnostics Market: By Product
Figure 8 Point-Of-Care Diagnostics Market: By Prescription Mode
Figure 9 Point-Of-Care Diagnostics Market: By End User
Figure 10 Market Dynamics
Figure 11 Value Chain Analysis: Point-Of-Care Diagnostics / Testing Market
Figure 12 Poc Diagnostics Market: Supply Chain
Figure 13 Pricing Trend: Poc Devices, 2013–2018
Figure 14 Porter’s Five Forces Analysis: Global Point-Of-Care Diagnostics / Testing Market, 2013
Figure 15 Point-Of-Care Diagnostics Market: Pest Analysis, 2013
Figure 16 Strategic Benchmarking: Technology Integration & Product Enhancement
Figure 17 Strategic Benchmarking: Entry Into Tumor/Cancer Testing Market
Figure 18 Global Poc Diagnostics (Excluding Blood Glucose Monitoring Kits) Market Share, By Key Player, 2012
Figure 19 Global Blood Glucose Monitoring Kits Market Share, By Key Player, 2012
Figure 20 Key Growth Strategies, 2011–2014
Figure 21 Abaxis, Inc.: Total Revenue, By Segment, 2013
Figure 22 Abaxis, Inc.: Total Revenue, By Product And Service Category, 2013
Figure 23 Abaxis, Inc.: Total Revenue, By Geography, 2013
Figure 24 Abbott Laboratories, Inc.: Total Revenue, By Segment, 2012
Figure 25 Abbott Laboratories, Inc.: Total Revenue, By Geography, 2012
Figure 26 Abbott Laboratories, Inc.: Market Strategy, 2011–2013
Figure 27 Alere, Inc.: Total Revenue, By Segments, 2012
Figure 28 Alere, Inc.: Total Revenue, By Geography, 2012
Figure 29 Alere, Inc. Market Strategy, 2011–2013
Figure 30 Bayer Ag: Total Revenue, By Segment, 2012
Figure 31 Danaher Corporation: Total Revenue, By Segment, 2012
Figure 32 Danaher Corporation: Life Sciences And Diagnostics Segment Revenue Mix, 2012
Figure 33 Danaher Corporation: Life Sciences & Diagnostics Segment Revenue, By Geography, 2012
Figure 34 Beckman Coulter, Inc.: Major Stratgy, 2011–2014
Figure 35 Becton, Dickinson And Company: Total Revenue, By Segment, 2013
Figure 36 Becton, Dickinson And Company: Total Revenue, By Geography, 2013
Figure 37 Becton, Dickinson And Company: Market Strategy, 2011–2014
Figure 38 Johnson & Johnson: Total Revenue, By Segment, 2012
Figure 39 Johnson & Johnson: Total Revenue, By Geography, 2012
Figure 40 Johnson & Johnson: Diagnostics Franchise Revenue, 2010–2012 ($Million) 
Figure 41 Johnson & Johnson: Market Strategy, 2011–2013
Figure 42 Nipro Corporation: Total Revenue, By Segment, 2013
Figure 43 Nipro Corporation: Total Revenue, By Geography, 2013
Figure 44 Roche Diagnostics Limited: Total Revenue, By Segment, 2013
Figure 45 Roche Diagnostics Limited: Total Revenue, By Geography, 2013
Figure 46 Roche Diagnostics Limited: Market Strategy, 2011–2013
Figure 47 Siemens Healthcare: Total Revenue, By Geography, 2013
Figure 48 Siemens Healthcare: Market Strategy, 2011–2013

The global point-of-care diagnostics market is expected to reach $27.5 billion by 2018, at a CAGR of 9.3% from 2013 to 2018. A number of factors such as the rising prevalence of lifestyle and infectious diseases, increasing usage of home-based POC devices, and decreasing number of technicians in central labs are driving the growth of the global market. Furthermore, growing government support and increasing private investments and venture funding to support new product development are other factors that are propelling the growth of the market. In addition, rising adoption of POC devices, expansion of therapeutic horizon, and technological advancements is further fueling the growth of this market.

However, a few pivotal factors such as lack of alignment with definitive central lab methods, and reluctance to change existing treatment practices are hindering the growth of this market. Moreover, disadvantages of point-of-care testing over central lab methods and recalls of leading glucose monitoring devices are the foremost challenges faced by industry players.

The global point-of-care diagnostics market is dominated by North America, followed by Europe, Asia-Pacific and the Rest of the World (RoW). North America will continue to dominate the market in the forecast period, followed by the Asia-Pacific. However, the Asia-Pacific region is expected to grow at the highest CAGR of ~13.6% from 2013 to 2018. Over the next five years, the growth of the market in the Asia-Pacific region is likely to be centered at Japan, China, and India. A number of factors such as the huge patient population base, increasing funding/investment toward the development of point of care diagnosticproducts, growing focus of both international and domestic players on the Asia-Pacific point-of-care diagnostics market, and large number of R&D activities are driving the growth of the market in the Asia-Pacific region.

New product launches is the key strategy followed by leading market players to ensure their growth in the Point-Of-Care Diagnostics / Testing market. Moreover, partnerships, agreements, collaboration, and joint ventures; mergers and acquisitions; and expansions are some other growth strategies adopted by industry players in the global market.

The point-of-care diagnostics market is a diversified and competitive market with a large number of players. The market is dominated by various players, depending on their core competencies. The key players in this market are Roche Diagnostics Ltd. (Switzerland), Abbott Laboratories (U.S.), Alere Inc. (U.S.), Siemens AG (Germany), and Beckman Coulter, Inc. (U.S.).

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports